Livacol 10
- Introducing Choliva: A cutting-edge treatment for primary biliary cholangitis (PBC) in adults.
- Powered by obeticholic acid, Choliva targets the Farnesoid X Receptor (FXR), modulating bile acid pathways.
- Offers options: Can be used alone or alongside ursodeoxycholic acid (UDCA) for patients unresponsive to traditional therapies.
- Careful monitoring and dosage adjustments ensure tailored treatment and improved patient outcomes.
Livacol 5
- Introducing Choliva: A cutting-edge treatment for primary biliary cholangitis (PBC) in adults.
- Powered by obeticholic acid, Choliva targets the Farnesoid X Receptor (FXR), modulating bile acid pathways.
- Offers options: Can be used alone or alongside ursodeoxycholic acid (UDCA) for patients unresponsive to traditional therapies.
- Careful monitoring and dosage adjustments ensure tailored treatment and improved patient outcomes.